PROject - Supportive and Palliative Care and INnOvation - Antwerp (Pro-Spinoza)

Not Applicable

Completed

• Conditions: Palliative Care; Primary Health Care

• Registration Number: NCT02266069
• Lead Sponsor: Bert Leysen

Brief Summary

It is important to provide high quality palliative care to all patients with a non-curable and life-limiting condition. The Care Pathway for Primary Palliative Care (CPPPC) provides tools for health care professionals to help them delivering palliative care timely and accurately.This study investigates whether the implementation of the CPPPC really helps to improve patients' lifes.

Detailed Description

Not available

Study Timeline

• Study Start: 2014-10
• Study First Submitted: 2014-10-10
• Study First Submitted QC: 2014-10-10
• Study First Posted: 2014-10-16
• Primary Completion: 2016-12
• Study Completion: 2016-12
• Status Verified: 2017-11
• Last Update Submitted: 2017-11-27
• Last Update Posted: 2017-11-29

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 24

Inclusion Criteria

• identified as a palliative care patient using the Surprise Question "Would you, as a family doctor, be surprised if this patient would die in the next 12 months?". If the answer is 'no', the patient is eligible for the study.

Exclusion Criteria

• not having signed the informed consent.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
percentage of deaths occurred in the hospital (of patients per family doctor/per research cluster)	6 months	The hypothesis is that the CPPPC reduces the percentage of deaths occurred in the hospital

Secondary Outcome Measures

Name	Time	Method
cost of health care consumption in the last year of life (of patients per family doctor/per research cluster)	6 months	The hypothesis is that the CPPPC reduces the cost of health care consumption in the last year of life
consumption of antibiotics in the last year of life (of patients per family doctor/per research cluster)	6 months	The hypothesis is that the CPPPC reduces the consumption of antibiotics in the last year of life
consumption of pain killers in the last year of life (of patients per family doctor/per research cluster)	6 months	The hypothesis is that the CPPPC augments the consumption of pain killers in the last year of life
consumption of (invasive) diagnostic and therapeutic procedures in the last year of life (of patients per family doctor/per research cluster)	6 months	The hypothesis is that the CPPPC reduces the consumption of (invasive) diagnostic and therapeutic procedures in the last year of life

Trial Locations

Locations (4)

Reliance; 🇧🇪 Mons, Hainaut, Belgium

Netwerk Palliatieve Zorg Limburg; 🇧🇪 Hasselt, Limburg, Belgium

Palliatieve Hulpverlening Antwerpen; 🇧🇪 Antwerp, Belgium

Palliabru; 🇧🇪 Brussels-Capital Region, Belgium